These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5444352)

  • 1. [Renal hemodynamic disorders in hepatic cirrhosis].
    Oancea R
    Med Interna (Bucur); 1970 Feb; 22(2):131-5. PubMed ID: 5444352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Functional nephropathy in the course of hepatic cirrhosis. Pathogenetic relationships with changes in hepatic blood flow].
    Merkel C; Zuin R; Grassetto M; Milani L; Merlo A; Gatta A
    Minerva Nefrol; 1979; 26(1):33-6. PubMed ID: 381989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamic interrelations in portal hypertension caused by hepatic cirrhosis].
    Garcia Civera R; Benages Martínez A; Lopez Merino F; Garcia-Conde Gomez FJ
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):19-34. PubMed ID: 5069488
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and functional aspects of the kidney in relation to renal and intrarenal hemodynamic changes during hepatic cirrhosis].
    Gatta A; Merkel C; Milani L; Caregaro L; Grassetto M; Lauro S; Zuin R
    Minerva Nefrol; 1979; 26(1):37-40. PubMed ID: 381990
    [No Abstract]   [Full Text] [Related]  

  • 5. [Functional renal reserve of patients with liver cirrhoses].
    Drozdov VN; Fedulenkova LV; Petrakov AV; Mikheeva OM
    Eksp Klin Gastroenterol; 2007; (5):51-5. PubMed ID: 18389598
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].
    Valla D; Poynard T; Bercoff E; Bataille C; Goldfarb G; Lebrec D
    Gastroenterol Clin Biol; 1984 Apr; 8(4):321-4. PubMed ID: 6735039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
    Orrego Matte H
    Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
    [No Abstract]   [Full Text] [Related]  

  • 10. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
    Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemostatic disorders in liver cirrhosis (in relation to the extent of portal hypertension)].
    Liehr H; Hörder MH; Mersch-Baumert K
    Acta Hepatosplenol; 1971; 18(3):166-71. PubMed ID: 5089183
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal pharmacology of 'shock' and its congeners.
    Bradley SE; Coelho JB
    Prog Biochem Pharmacol; 1972; 7():1-58. PubMed ID: 4405325
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
    Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
    J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial dysfunction in cirrhosis.
    Iwakiri Y; Groszmann RJ
    J Hepatol; 2007 May; 46(5):927-34. PubMed ID: 17391799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of renal tubular function in hepatic cirrhosis].
    Oancea R
    Med Interna (Bucur); 1972 May; 24(5):529-32. PubMed ID: 5049865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical aspects and physiopathology of functional renal insufficiency in hepatic cirrhosis].
    García Puig J; Mateos Antón F; Gaspar G; Fernández Capitán MC; Gil Aguado A
    Rev Clin Esp; 1982 Oct; 167(1):1-3. PubMed ID: 7178578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.